EBR Systems Advances Cardiac Pacing Device Rollout With 46 Commercial Implants in Q2

MT Newswires Live

07/30

EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market release to 117, according to a Thursday filing with the Australian bourse.

The company said it signed an additional 17 purchasing contracts during the quarter, taking overall purchasing contracts signed to 52.

It added that 90 physicians at 30 sites are now trained to implant the WiSE system, with 26 of them trained during the second quarter.

Additionally, EBR Systems expects second-quarter revenue in the range of $2.5 million to $2.6 million. It sees "encouraging numbers" of patients being identified and scheduled for WiSE implants in the second half of the year.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2655841058"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2655841058\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2655841058?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-30 11:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2655841058","market":"us","top_or_hot":-1,"title":"EBR Systems Advances Cardiac Pacing Device Rollout With 46 Commercial Implants in Q2","media":"MT Newswires Live","content":"<html><body><p> EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market release to 117, according to a Thursday filing with the Australian bourse.</p><p>The company said it signed an additional 17 purchasing contracts during the quarter, taking overall purchasing contracts signed to 52.</p><p>It added that 90 physicians at 30 sites are now trained to implant the WiSE system, with 26 of them trained during the second quarter.</p><p>Additionally, EBR Systems expects second-quarter revenue in the range of $2.5 million to $2.6 million. It sees \"encouraging numbers\" of patients being identified and scheduled for WiSE implants in the second half of the year.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EBR Systems Advances Cardiac Pacing Device Rollout With 46 Commercial Implants in Q2</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEBR Systems Advances Cardiac Pacing Device Rollout With 46 Commercial Implants in Q2\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-07-30 11:38</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market release to 117, according to a Thursday filing with the Australian bourse.</p><p>The company said it signed an additional 17 purchasing contracts during the quarter, taking overall purchasing contracts signed to 52.</p><p>It added that 90 physicians at 30 sites are now trained to implant the WiSE system, with 26 of them trained during the second quarter.</p><p>Additionally, EBR Systems expects second-quarter revenue in the range of $2.5 million to $2.6 million. It sees \"encouraging numbers\" of patients being identified and scheduled for WiSE implants in the second half of the year.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7007","symbol_name":"醫療保健設備","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2655841058","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2655841058","pubTimestamp":1785382703,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market relea","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7007":"医疗保健设备","EBR.AU":"EBR SYSTEMS INC-CDI"},"translate_title":"EBR Systems 在第二季度推出 46 台商业植入物，推进心脏起搏设备","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBR.AU":1},"content_text":"EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market release to 117, according to a Thursday filing with the Australian bourse.The company said it signed an additional 17 purchasing contracts during the quarter, taking overall purchasing contracts signed to 52.It added that 90 physicians at 30 sites are now trained to implant the WiSE system, with 26 of them trained during the second quarter.Additionally, EBR Systems expects second-quarter revenue in the range of $2.5 million to $2.6 million. It sees \"encouraging numbers\" of patients being identified and scheduled for WiSE implants in the second half of the year.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}